Regulation of gamma-secretase activating protein by the 5Lipoxygenase: in vitro and in vivo evidence
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of gamma-secretase activating protein by the 5Lipoxygenase: in vitro and in vivo evidence
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-06-16
DOI
10.1038/srep11086
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gamma Secretase-Activating Protein Is a Substrate for Caspase-3: Implications for Alzheimer’s Disease
- (2015) Jin Chu et al. BIOLOGICAL PSYCHIATRY
- A common GSAP promoter variant contributes to Alzheimer's disease liability
- (2014) Min Zhu et al. NEUROBIOLOGY OF AGING
- Novel lipid signaling pathways in Alzheimer's disease pathogenesis
- (2013) Phillip F. Giannopoulos et al. BIOCHEMICAL PHARMACOLOGY
- Imatinib methanesulfonate reduces hippocampal amyloid-beta and restores cognitive function following repeated endotoxin exposure
- (2013) Marielle K. Weintraub et al. BRAIN BEHAVIOR AND IMMUNITY
- 5-Lipoxygenase Inhibitor Zileuton Inhibits Neuronal Apoptosis Following Focal Cerebral Ischemia
- (2013) Song-sheng Shi et al. INFLAMMATION
- Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease
- (2013) P F Giannopoulos et al. MOLECULAR PSYCHIATRY
- 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of alzheimer disease
- (2012) Jin Chu et al. ANNALS OF NEUROLOGY
- Purification and Characterization of the Human γ-Secretase Activating Protein
- (2012) Catherine L. Deatherage et al. BIOCHEMISTRY
- Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice
- (2012) Jin Chu et al. Molecular Neurodegeneration
- Lifelong Management of Amyloid-Beta Metabolism to Prevent Alzheimer's Disease
- (2012) Sam Gandy NEW ENGLAND JOURNAL OF MEDICINE
- Immunohistochemical characterization of γ-secretase activating protein expression in Alzheimer's disease brains
- (2011) J. Satoh et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Overexpression of 5-Lipoxygenase Increases the Neuronal Vulnerability of PC12 Cells to Aβ42
- (2011) Ze-Jian WANG et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- 5-lipoxygenase as an endogenous modulator of amyloid beta formation in vivo
- (2010) Jin Chu et al. ANNALS OF NEUROLOGY
- Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease
- (2010) Gen He et al. NATURE
- 5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor α-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice
- (2009) Marcos Martínez-Clemente et al. HEPATOLOGY
- Increased 5-Lipoxygenase Immunoreactivity in the Hippocampus of Patients With Alzheimer's Disease
- (2008) Milos D. Ikonomovic et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Inhibition and modulation of γ-secretase for Alzheimer’s disease
- (2008) Michael S. Wolfe Neurotherapeutics
- 5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer’s disease
- (2007) Omidreza Firuzi et al. FASEB JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now